Evommune, Inc.
General ticker "EVMN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $596.4M (TTM average)
Evommune, Inc. does not follow the US Stock Market performance with the rate: -27.8%.
Estimated limits based on current volatility of 6.8%: low 6.42$, high 7.36$
Short-term EVMN quotes
Long-term EVMN plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $13.00MM |
| Operating Expenses | $94.07MM |
| Operating Income | $-81.07MM |
| Non-Operating Income | $12.20MM |
| R&D Expense | $74.04MM |
| Income(Loss) | $-68.87MM |
| Net Income(Loss)* | $-68.87MM |
| Stockholders Equity | $205.57MM |
| Assets | $224.95MM |
| Operating Cash Flow | $-76.44MM |
| Capital expenditure | $0.23MM |
| Investing Cash Flow | $-115.31MM |
| Financing Cash Flow | $220.76MM |
| Earnings Per Share** | $-11.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.